Goodman Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
1,326
-18,469
| -93% | -$3.43M | 0.08% | 51 |
|
|
2025
Q1 | $4.15M | Buy |
19,795
+2,295
| +13% | +$481K | 1.26% | 30 |
|
|
2024
Q4 | $3.11M | Buy |
17,500
+1,966
| +13% | +$349K | 0.92% | 34 |
|
|
2024
Q3 | $3.07M | Buy |
15,534
+1,620
| +12% | +$320K | 0.88% | 34 |
|
|
2024
Q2 | $2.39M | Buy |
13,914
+13,567
| +3,910% | +$2.33M | 0.71% | 34 |
|
|
2024
Q1 | $63.2K | Hold |
347
| – | – | 0.02% | 96 |
|
|
2023
Q4 | $53.8K | Hold |
347
| – | – | 0.02% | 91 |
|
|
2023
Q3 | $51.7K | Sell |
347
-134
| -28% | -$20K | 0.02% | 93 |
|
|
2023
Q2 | $64.8K | Hold |
481
| – | – | 0.02% | 80 |
|
|
2023
Q1 | $76.7K | Buy |
481
+134
| +39% | +$21.4K | 0.04% | 68 |
|
|
2022
Q4 | $56K | Hold |
347
| – | – | 0.03% | 71 |
|
|
2022
Q3 | $47K | Hold |
347
| – | – | 0.03% | 73 |
|
|
2022
Q2 | $53K | Buy |
+347
| New | +$53K | 0.02% | 75 |
|